Pediatric Respirology and Critical Care Medicine

REVIEW ARTICLE
Year
: 2020  |  Volume : 4  |  Issue : 2  |  Page : 21--24

SARS-CoV-2 vaccines: A brief review


Brandon Chatani1, Daniel K Ng2 
1 Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Miami Miller School of Medicine, Miami, Florida, USA
2 Department of Paediatrics, Hong Kong Sanatorium & Hospital, Hong Kong, China

Correspondence Address:
Brandon Chatani
Assistant Professor of the Department of Pediatrics, Division of Pediatric Infectious Diseases, Associate Program Director of the Pediatric Infectious Disease Fellowship, University of Miami Miller School of Medicine, Miami, Florida
USA

SARS-CoV-2 has immensely changed the landscape in how vaccines are researched and developed. The timeline truncated for the propose of meeting the grave demand. Children stand to benefit from herd immunity for multiple reasons. Protection from SARS-CoV-2 would not only protect children from COVID but also a unique entity called Multisystem Inflammatory Syndrome in Children (MISC). Thus, it is vital that general pediatricians and practitioners who care for children to have foundational knowledge regarding the ever-expanding array of soon to be available COVID19 vaccines along with the potential pitfalls of their rushed development and implementation. This article seeks to provide a brief review of the most prominent COVID19 vaccines under development with intention for Pediatric use as well as recall historical knowledge regarding rushed development of respiratory viral vaccines that resulted in unintended consequences.


How to cite this article:
Chatani B, Ng DK. SARS-CoV-2 vaccines: A brief review.Pediatr Respirol Crit Care Med 2020;4:21-24


How to cite this URL:
Chatani B, Ng DK. SARS-CoV-2 vaccines: A brief review. Pediatr Respirol Crit Care Med [serial online] 2020 [cited 2021 Apr 16 ];4:21-24
Available from: https://www.prccm.org/article.asp?issn=2543-0343;year=2020;volume=4;issue=2;spage=21;epage=24;aulast=Chatani;type=0